View top level findings and download detailed abstracts
The purpose of this study was to assess the growth and tolerance of pediatric patients who transitioned from a hypoallergenic formula to a pea protein plant-based formula (PPPBF).
The purpose of this study was to describe the specific symptom frequency of constipation, diarrhea, vomiting, bloating and adherence reported in pediatric patients who have been on a pea protein plant-based enteral formula (PP PBEF).
This study investigated patient-reported outcomes of pediatric and adult users of plant-based enteral formulas containing intact or hydrolyzed pea protein. A total of 392 patients and caregivers completed the online survey.
The purpose of this study was to assess the outcomes of three pediatric Crohn’s disease patients in clinical remission who were started on pediatric peptide plant-based enteral nutrition (PPBEN) in conjunction with Crohn’s disease exclusion diet (CDED).
The purpose of this study was to document the successful concomitant use of a plant-based, phytonutrient-containing enteral formula and immunosuppressive medications.
A study on the usage and outcomes of pediatric and adult patients with a medical need for nutritional formula who had been prescribed a plant-based, organic, calorically dense peptide formula (Kate Farms® Peptide 1.5).
1. Bailey, M., Millovich, V., Komar, S. Weight gain in oncology patients using a plant-based oral nutrition supplement. Clinical Nutrition ESPEN. 2020; 40:661.
2. Dufau L., (2010). Prevalence of malnutrition in cancer patients. Diaeta 28, 31–36.